IGHE and asthma: Toledo et al. [137] observed that sakuranetin decreased IgE specific antibodies, eosinophil inflammation, AHR, and airway remodeling by reducing oxidative stress, Th2 pro-inflammatory cytokines and chemokines, and NF-κB activation in inflammatory cells in an experimental asthma model.